Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC [Phase 2]

View source ↗

Summary

Phase II clinical study evaluating HLX07 combination therapy or HLX07 monotherapy in advanced esophageal squamous cell carcinoma or esophageal adenosquamous car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenosquamous Carcinoma
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• HLX07 (HLX07)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: ESCC or Esophageal Adenosquamous Carcinoma | Phase 2 | Status: UNKNOWN